Abstract

BackgroundIntermittent theta-burst stimulation priming (iTBS-P) can improve clinical outcome of patients with Major Depressive Disorder (MDD) who do not show early benefit from 10 Hz stimulation of left dorsolateral prefrontal cortex (DLPFC), also known as high-frequency left-sided (HFL) stimulation. The intensity and pulse number for iTBS-P needed to induce clinical benefit have not been systematically examined. ObjectiveTo study the effect of intensity and pulse number on the clinical efficacy of iTBS-P. MethodsWe conducted a retrospective review of 71 participants who received at least five sessions of HFL with limited clinical benefit and received iTBS-P augmentation for between 5 and 25 sessions. Intensity of iTBS-P priming stimuli ranged from 75 to 120% of motor threshold (MT) and pulse number ranged from 600 to 1800. Associations among intensity, pulse number, and clinical outcome were analyzed using a mixed methods linear model with change in IDS-SR as the primary outcome variable, priming stimulation intensity (subthreshold or suprathreshold), pulse number (<1200 or >1200 pulses), and gender as fixed factors, and number of iTBS-P treatments and age as continuous covariates. ResultsSubjects who received subthreshold intensity iTBS-P experienced greater reduction in depressive symptoms than those who received suprathreshold iTBS-P (p = 0.011) with no effect of pulse number after controlling for stimulus intensity. ConclusionsSubthreshold intensity iTBS-P was associated with greater clinical improvement than suprathreshold stimulation. This finding is consistent with iTBS-P acting through homeostatic plasticity mechanisms.

Highlights

  • Repetitive Transcranial Magnetic Stimulation of the left dorsolateral prefrontal cortex (DLPFC) is an established noninvasive brain stimulation treatment for Major Depressive Disorder (MDD)

  • We examined whether Intermittent theta-burst stimulation priming (iTBS-P) intensity or pulse number were associated with better clinical outcome in subjects who failed to show early benefit from high-frequency left-sided (HFL) Repetitive Transcranial Magnetic Stimulation (rTMS) stimulation of left DLPFC

  • Subjects received a mean of 12.5 ± 4.2 HFL rTMS treatment sessions before receiving a mean of 16.5 ± 4.7 intermittent theta burst stimulation (iTBS)-P sessions during their treatment courses

Read more

Summary

Introduction

Repetitive Transcranial Magnetic Stimulation (rTMS) of the left dorsolateral prefrontal cortex (DLPFC) is an established noninvasive brain stimulation treatment for Major Depressive Disorder (MDD) Both 10 Hz (high-frequency left, or HFL rTMS) and intermittent theta burst stimulation (iTBS) are thought to induce synaptic plasticity and long-term potentiation (LTP) [1]. These approaches yield response rates between 40 and 50% and remission rates of up to 30% [2e5], leaving room for improvement. Intermittent theta-burst stimulation priming (iTBS-P) can improve clinical outcome of patients with Major Depressive Disorder (MDD) who do not show early benefit from 10 Hz stimulation of left dorsolateral prefrontal cortex (DLPFC), known as high-frequency left-sided (HFL) stimulation. This finding is consistent with iTBS-P acting through homeostatic plasticity mechanisms

Objectives
Methods
Results
Discussion
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call